Dennis Bergmans

Prof. Dennis Bergmans

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 August 2017 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
FVFrank van de Veerdonk
Frank van de Veerdonk
EKEva Kolwijck
Eva Kolwijck
PLPieter P. A. Lestrade
Pieter P. A. Lestrade
CHCaspar J. Hodiamont
Caspar J. Hodiamont
BRBart Rijnders
Bart Rijnders
PVPaul Verweij
Paul Verweij

1 January 2009 in Critical Care
Verified
Journal Article
Open access
PDF file
BWBastiaan Hj Wittekamp
Bastiaan Hj Wittekamp
WMWalther Nka van Mook
Walther Nka van Mook
DTDave Ht Tjan
Dave Ht Tjan
JZJan H Zwaveling
Jan H Zwaveling
DBDennis Bergmans
Dennis Bergmans
Laryngeal edema is a frequent complication of intubation. It often presents shortly after extubation as post-extubation stridor and results from damage to the mucosa of the larynx. Mucosal damage is caused by pressure and ischemia resulting in an inflammatory response. Laryngeal edema may compromise the airway necessitating reintubation. Several studies show that a positive cuff leak test combined with the presence of risk factors can identify patients with increased risk for laryngeal edema. Meta-analyses show that pre-emptive administration of a multiple-dose regimen of glucocorticosteroids can reduce the incidence of laryngeal edema and subsequent reintubation. If post-extubation edema occurs this may necessitate medical intervention. Parenteral administration of corticosteroids, epinephrine nebulization and inhalation of a helium/oxygen mixture are potentially effective, although this has not been confirmed by randomized controlled trials. The use of non-invasive positive pressure ventilation is not indicated since this will delay reintubation. Reintubation should be considered early after onset of laryngeal edema to adequately secure an airway. Reintubation leads to increased cost, morbidity and mortality.

29 May 2021 in Intensive Care Medicine
Verified
Journal Article
Closed access
PDF file
LVLore Vanderbeke
Lore Vanderbeke
Nico JanssenNico Janssen
Nico Janssen
DBDennis Bergmans
Dennis Bergmans
MBMarc Bourgeois
Marc Bourgeois
JBJochem Buil
Jochem Buil
TWTom Wolfs
Tom Wolfs

29 September 2015 in BMC Pulmonary Medicine
Verified
Journal Article
Open access
PDF file
RSR.M. Schnabel
R.M. Schnabel
KVKim Hubertus van der Velden
Kim Hubertus van der Velden
AOA Osinski
A Osinski
GRGernot Rohde
Gernot Rohde
PRP M H J Roekaerts
P M H J Roekaerts
DBDennis Bergmans
Dennis Bergmans
Flexible, fibreoptic bronchoscopy (FFB) and bronchoalveolar lavage (BAL) have been used for diagnostic purposes in critically ill ventilated patients. The additional diagnostic value compared to tracheal aspirations in ventilator-associated pneumonia (VAP) has been questioned. Nevertheless, BAL can provide extra information for the differential diagnosis of respiratory disease and good antibiotic stewardship. These benefits should outweigh potential hazards caused by the invasiveness of this diagnostic technique. The focus of the present study was on the clinical course and complications of patients following BAL procedures up to 24 h. Hundred sixty-four FFB guided BAL procedures for suspected pneumonia were analysed in an observational study. The clinical course of patients was monitored by respiratory and haemodynamic data before BAL, 1 and 24 h after BAL. Complications were defined and registered. Factors associated with complications were analysed by logistic regression. Clinical course: a decrease in average pO2/FiO2 ratio 1 h after BAL from 29 kPa (218 mmHg) to 25 kPa (189 mmHg) (p < 0.05) was observed which fully recovered within 24 h. Respiratory complications: the incidence of procedure related hypo-oxygenation (SaO2 ≤ 88 %) and/or bronchospasm was 9 %; a decrease of >25 % PaO2/FiO2 ratio 1 h after BAL was found in 29 % of patients; no bleeding or pneumothorax were registered. Haemodynamic complications: there were no cases of hypertension and cardiac rhythm disturbances; haemodynamic instability within the first 24 h after BAL was recorded in 22 %; this was correlated with a cardiovascular diagnosis at admission (OR 2.9; 95 % CI 1.2 - 6.7) and the presence of cardiovascular co-morbidity (OR 3.5; 95 % CI 1.5 – 8.3). The incidence of bacteraemia was 7 %. There was no case of procedure related death. Frequently occurring haemodynamic and respiratory instability but no cases of cardiac rhythm disturbances, bleeding, pneumothorax or procedure related death were attributable to diagnostic FFB and BAL. The procedures should be conducted under careful supervision by experienced physicians. Only a randomized controlled trial that compares diagnostic FFB and BAL with a non-invasive strategy could ultimately establish the safety profile and clinical utility of these procedures in critically ill ventilated patients.

29 May 2018 in Journal of Clinical Monitoring and Computing
Verified
Journal Article
Open access
PDF file
SHSerge Heines
Serge Heines
USUlrich Strauch
Ulrich Strauch
MPMarcel C. G. van de Poll
Marcel C. G. van de Poll
PRPaul M. H. J. Roekaerts
Paul M. H. J. Roekaerts
DBDennis Bergmans
Dennis Bergmans
To report on our clinical experience using EIT in individualized PEEP titration in ARDS. Using EIT assessment, we optimized PEEP settings in 39 ARDS patients. The EIT PEEP settings were compared with the physicians’ PEEP settings and the PEEP settings according to the ARDS network. We defined a PEEP difference equal to or greater than 4 cm H2O as clinically relevant. Changes in lung compliance and PaO2/FiO2-ratio were compared in patients with EIT-based PEEP adjustments and in patients with unaltered PEEP. In 28% of the patients, the difference in EIT-based PEEP and physician-PEEP was clinically relevant; in 36%, EIT-based PEEP and physician-PEEP were equal. The EIT-based PEEP disagreed with the PEEP settings according to the ARDS network. Adjusting PEEP based upon EIT led to a rapid increase in lung compliance and PaO2/FiO2-ratio. However, this increase was also observed in the group where the PEEP difference was less than 4 cm H2O. We hypothesize that this can be attributed to the alveolar recruitment during the PEEP trial. EIT based individual PEEP setting appears to be a promising method to optimize PEEP in ARDS patients. The clinical impact, however, remains to be established.

1 April 2021 in Journal of Critical Care
Verified
Journal Article
Open access
JBJulia L.M. Bels
Julia L.M. Bels
SKSander M.J. van Kuijk
Sander M.J. van Kuijk
CGChahinda Ghossein-Doha
Chahinda Ghossein-Doha
FTFabian H. Tijssen
Fabian H. Tijssen
RGRob J.J. van Gassel
Rob J.J. van Gassel
BBBas Van Bussl
Bas Van Bussl
The majority of patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are admitted to the Intensive Care Unit (ICU) for mechanical ventilation. The role of multi-organ failure during ICU admission as driver for outcome remains to be investigated yet. Prospective cohort of mechanically ventilated critically ill with SARS-CoV-2 infection. 94 participants of the MaastrICCht cohort (21% women) had a median length of stay of 16 days (maximum of 77). After division into survivors (n = 59) and non-survivors (n = 35), we analysed 1555 serial SOFA scores using linear mixed-effects models. Survivors improved one SOFA score point more per 5 days (95% CI: 4–8) than non-survivors. Adjustment for age, sex, and chronic lung, renal and liver disease, body-mass index, diabetes mellitus, cardiovascular risk factors, and Acute Physiology and Chronic Health Evaluation II score did not change this result. This association was stronger for women than men (P-interaction = 0.043). The decrease in SOFA score associated with survival suggests multi-organ failure involvement during mechanical ventilation in patients with SARS-CoV-2. Surviving women appeared to improve faster than surviving men. Serial SOFA scores may unravel an unfavourable trajectory and guide decisions in mechanically ventilated patients with SARS-CoV-2.